Will JAK1/2 inhibitors change the standard of care for myelofibrosis?

Detalles Bibliográficos
Autor principal: Jung, Chul Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2012
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538792/
https://www.ncbi.nlm.nih.gov/pubmed/23319999
http://dx.doi.org/10.5045/kjh.2012.47.4.241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538792/
https://www.ncbi.nlm.nih.gov/pubmed/23319999
http://dx.doi.org/10.5045/kjh.2012.47.4.241

Ejemplares similares